Mr. L. Jack Staley, Sr. has joined the AlgiSys team in the pursuit of protecting the world's natural resources and improving human and animal health. His background includes roles as Chairman of SGS AG Wealth Management Company, Zurich; Executive Director of Prudential Financial and Dryden Wealth Management Zurich and London and Asia; GM of Bankers Trust New York Corporation, Zurich; The Boston Company in Boston and London and Chase-Lincoln First Bank. Jack holds an MBA in Finance from Wharton School, University of Pennsylvania. He serves as a Board Member of Tufts Medical Center, Prescribers Choice, Vice Chairman of The Children’s Diagnostic and Treatment Center, and other charity Boards. —
“Alternatives to fish sources for omega-3 products must be found as the market is expected to grow to $57 billion by 2025,” states Mr. Staley, a veteran of the global banking, financial services, and investment banking industries, “the destruction to our planet caused by overfishing and the depletion of our fish stocks is escalating, new unique solutions such as utilizing the power of algae are desperately needed in order to restore the natural balance and create a positive impact.”
According to Save Our Seas, 75 percent of the world’s fish populations are removed faster than they can reproduce, 80 percent of that is completely exploited, and about 90 percent of all large predatory fish (i.e. tuna, sharks, cod) have vanished. Scientists now believe that fisheries will collapse by 2050 if current practices continue.
To check out AlgiSys entire team go to www.algisys.com/team
About the Company: AlgiSys LLC, an Environmental, Social, Governance (ESG) company produces EPA omega-3 products from microalgae, replacing fish its primary source. AlgiSys has created an environmentally sustainable and economically viable source for high quality, all natural, omega-3 EPA and plant-based vegan protein with 7 international patents. AlgiSys was recently featured in USA Today and Market Watch.
Release ID: 88966144